Supernus Pharmaceuticals, Inc. recalls
2 recalls filed under Supernus Pharmaceuticals, Inc.. The most recent was published September 9, 2026.
-
Class III · last month
Supernus Pharmaceuticals, Inc. Trokendi XR, extended-release capsules, 50 mg recall: Failed dissolution specifications
Failed dissolution specifications.
-
Class III · 3 months ago
Supernus Pharmaceuticals, Inc. Trokendi XR, topiramate extended-release capsules recall: Failed Dissolution Specifications
Failed Dissolution Specifications
About this page
Supernus Pharmaceuticals, Inc. appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.